Cargando…
Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer
There is still a great unmet medical need concerning diagnosis and treatment of breast cancer which could be addressed by utilizing specific molecular targets. Tumor-associated MUC1 is expressed on over 90 % of all breast cancer entities and differs strongly from its physiological form on epithelial...
Autores principales: | Stergiou, Natascha, Nagel, Johannes, Pektor, Stefanie, Heimes, Anne-Sophie, Jäkel, Jörg, Brenner, Walburgis, Schmidt, Marcus, Miederer, Matthias, Kunz, Horst, Roesch, Frank, Schmitt, Edgar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775261/ https://www.ncbi.nlm.nih.gov/pubmed/31588183 http://dx.doi.org/10.7150/ijms.35452 |
Ejemplares similares
-
Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary – a review
por: Jung, Dennis, et al.
Publicado: (2023) -
Immunomodulating Therapies in Breast Cancer—From Prognosis to Clinical Practice
por: Schmidt, Marcus, et al.
Publicado: (2021) -
Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA
por: Miederer, Matthias, et al.
Publicado: (2021) -
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic
por: Schwab, Roxana, et al.
Publicado: (2022) -
In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET
por: Pektor, Stefanie, et al.
Publicado: (2018)